Cargando…
SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies
Mothers against decapentaplegic homolog 7 (SMAD7) inhibits the transforming growth factor-β (TGF-β) signaling pathway, which regulates carcinogenesis and cancer progression. A number of studies have reported that SMAD7 polymorphisms (rs4464148, rs4939827, and rs12953717) are associated with colorect...
Autores principales: | Huang, Yongsheng, Wu, Wenting, Nie, Meng, Li, Chuang, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342761/ https://www.ncbi.nlm.nih.gov/pubmed/28070019 http://dx.doi.org/10.18632/oncotarget.12285 |
Ejemplares similares
-
Polymorphism of SMAD7 gene (rs2337104) and risk of colorectal cancer in an Iranian population: a case-control study
por: Akbari, Zahra, et al.
Publicado: (2014) -
Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk
por: Abd El-Fattah, Amal Ahmed, et al.
Publicado: (2018) -
Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results
por: Yao, Kunhou, et al.
Publicado: (2015) -
SMAD7 rs4939827 variant contributes to colorectal cancer risk in Chinese population
por: Zhang, Chunze, et al.
Publicado: (2017) -
A Common SMAD7 Variant Is Associated with Risk of Colorectal Cancer: Evidence from a Case-Control Study and a Meta-Analysis
por: Song, Qibin, et al.
Publicado: (2012)